"0 3 t" Pill Images
The following drug pill images match your search criteria.

NTO 80 Pfizer
Troxyca ER
- Strength
- naltrexone hydrochloride 9.6 mg / oxycodone hydrochloride 80 mg
- Imprint
- NTO 80 Pfizer
- Color
- Gray & Red
- Shape
- Capsule/Oblong
1 / 2
Loading
TEVA 7028
Amlodipine Besylate and Olmesartan Medoxomil
- Strength
- 5 mg / 40 mg
- Imprint
- TEVA 7028
- Color
- Yellow
- Shape
- Capsule/Oblong
TEVA 7584
Ezetimibe and Simvastatin
- Strength
- 10 mg / 10 mg
- Imprint
- TEVA 7584
- Color
- White
- Shape
- Capsule/Oblong
TEVA 7585
Ezetimibe and Simvastatin
- Strength
- 10 mg / 20 mg
- Imprint
- TEVA 7585
- Color
- White
- Shape
- Capsule/Oblong

Logo Lannett 1868
Amantadine Hydrochloride
- Strength
- 100 mg
- Imprint
- Logo Lannett 1868
- Color
- Red
- Shape
- Capsule/Oblong
Featured

Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Reviews & ratings

t 2731
Methylphenidate Hydrochloride Extended-Release
- Strength
- 10 mg
- Imprint
- t 2731
- Color
- White
- Shape
- Round

1 / 2
Loading
SYPRINE ATON 710
Trientine Hydrochloride
- Strength
- 250 mg
- Imprint
- SYPRINE ATON 710
- Color
- Brown
- Shape
- Capsule/Oblong

1 / 3
Loading
WATSON 384
Kelnor 1/50
- Strength
- ethinyl estradiol 50 mcg / ethynodiol diacetate 1 mg
- Imprint
- WATSON 384
- Color
- Pink
- Shape
- Round
TWi T112 135mg
Fenofibric Acid Delayed-Release
- Strength
- 135 mg
- Imprint
- TWi T112 135mg
- Color
- Blue & Yellow
- Shape
- Capsule/Oblong
1 / 2
Loading
TEVA 7768

TEVA 8229 TEVA 8229
Sunitinib Malate
- Strength
- 37.5 mg
- Imprint
- TEVA 8229 TEVA 8229
- Color
- Yellow
- Shape
- Capsule/Oblong

TEVA 8231 TEVA 8231
Sunitinib Malate
- Strength
- 50 mg
- Imprint
- TEVA 8231 TEVA 8231
- Color
- Brown
- Shape
- Capsule/Oblong

TEMOZOLOMIDE 250 mg
Temozolomide
- Strength
- 250 mg
- Imprint
- TEMOZOLOMIDE 250 mg
- Color
- Gray & White
- Shape
- Capsule/Oblong

Lannett 4181
Prazosin Hydrochloride
- Strength
- 2 mg
- Imprint
- Lannett 4181
- Color
- Gray & Red
- Shape
- Capsule/Oblong

PT A18
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.